Coxsackie and Adenovirus Receptor-Like Membrane Protein
"Coxsackie and Adenovirus Receptor-Like Membrane Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An Ig superfamily transmembrane protein that localizes to junctional complexes that occur between ENDOTHELIAL CELLS and EPTHELIAL CELLS. The protein may play a role in cell-cell adhesion and is the primary site for the attachment of ADENOVIRUSES during infection.
| Descriptor ID |
D062727
|
| MeSH Number(s) |
D12.776.395.550.200.537.500 D12.776.543.550.200.537.500 D12.776.543.750.830.124 D12.776.543.940.600.500 D23.050.301.350.537.500
|
| Concept/Terms |
Coxsackie and Adenovirus Receptor-Like Membrane Protein- Coxsackie and Adenovirus Receptor-Like Membrane Protein
- Coxsackie and Adenovirus Receptor Like Membrane Protein
- CXADR-Like Membrane Protein
- CXADR Like Membrane Protein
- Coxsackie-Adenovirus Receptor
- Coxsackie Adenovirus Receptor
- Receptor, Coxsackie-Adenovirus
- CAR (Coxsackie-Adenovirus Receptor)
- Adipocyte Adhesion Molecule
- Adhesion Molecule, Adipocyte
- CAR-Like Membrane Protein
- CAR Like Membrane Protein
|
Below are MeSH descriptors whose meaning is more general than "Coxsackie and Adenovirus Receptor-Like Membrane Protein".
Below are MeSH descriptors whose meaning is more specific than "Coxsackie and Adenovirus Receptor-Like Membrane Protein".
This graph shows the total number of publications written about "Coxsackie and Adenovirus Receptor-Like Membrane Protein" by people in this website by year, and whether "Coxsackie and Adenovirus Receptor-Like Membrane Protein" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 3 | 3 |
| 2003 | 0 | 3 | 3 |
| 2005 | 0 | 4 | 4 |
| 2006 | 0 | 7 | 7 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 4 | 4 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Coxsackie and Adenovirus Receptor-Like Membrane Protein" by people in Profiles.
-
CAR expression in invasive breast carcinoma and its effect on adenovirus transduction efficiency. Breast Cancer Res. 2024 Sep 10; 26(1):131.
-
JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy. J Exp Med. 2021 10 04; 218(10).
-
Characterization of type I interferon pathway during hepatic differentiation of human pluripotent stem cells and hepatitis C virus infection. Stem Cell Res. 2015 Sep; 15(2):354-364.
-
Tear-mediated delivery of nanoparticles through transcytosis of the lacrimal gland. J Control Release. 2015 Jun 28; 208:2-13.
-
Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma. Cancer Sci. 2013 Nov; 104(11):1433-9.
-
Variants in CXADR and F2RL1 are associated with blood pressure and obesity in African-Americans in regions identified through admixture mapping. J Hypertens. 2012 Oct; 30(10):1970-6.
-
ZEB1 limits adenoviral infectability by transcriptionally repressing the coxsackie virus and adenovirus receptor. Mol Cancer. 2011 Jul 27; 10:91.
-
Design and cellular internalization of genetically engineered polypeptide nanoparticles displaying adenovirus knob domain. J Control Release. 2011 Oct 30; 155(2):218-26.
-
A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibition. PLoS Comput Biol. 2011 Feb; 7(2):e1001085.
-
Molecular insights into γδ T cell costimulation by an anti-JAML antibody. Structure. 2011 Jan 12; 19(1):80-9.